Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nienke M Ter Haar

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Current Opinion in Rheumatology|March 27, 2014
Treatment of hereditary autoinflammatory diseasesNienke M Ter Haar, Joost Frenkel
Academic Medicine : Journal of the Association of American Medical Colleges|April 22, 2021
Developing Entrustable Professional Activities for the Training of Translational Scientists: A Modified Delphi StudyMargot M Weggemans, Nienke M Ter Haar, Berent Prakken, et al.
Clinical Immunology (Orlando, Fla.)|November 1, 2012
Mevalonate kinase deficiency, a metabolic autoinflammatory diseaseRobert van der Burgh, Nienke M Ter Haar, Marianne L Boes, et al.
Nederlands Tijdschrift Voor Geneeskunde|May 21, 2010
[DIRA: life-threatening but treatable inherited inflammatory disease]Nienke M ter Haar, Annet van Royen, Mariëlle E van Gijn, et al.
Pediatric Rheumatology Online Journal|September 22, 2016
The human microbiome and juvenile idiopathic arthritisAnouk Verwoerd, Nienke M Ter Haar, Sytze de Roock, et al.
JIMD Reports|September 28, 2015
Diagnostic Value of Urinary Mevalonic Acid Excretion in Patients with a Clinical Suspicion of Mevalonate Kinase Deficiency (MKD)Jerold Jeyaratnam, Nienke M Ter Haar, Monique G M de Sain-van der Velden, et al.
Pediatric Rheumatology Online Journal|March 23, 2018
The safety of live-attenuated vaccines in patients using IL-1 or IL-6 blockade: an international surveyJerold Jeyaratnam, Nienke M Ter Haar, Helen J Lachmann, et al.
Rheumatology (Oxford, England)|June 23, 2018
Prediction of inactive disease in juvenile idiopathic arthritis: a multicentre observational cohort studyEvert H Pieter van Dijkhuizen, Orfeas Aidonopoulos, Nienke M Ter Haar, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 29, 2018
Microbiome Analytics of the Gut Microbiota in Patients With Juvenile Idiopathic Arthritis: A Longitudinal Observational Cohort StudyE H Pieter van Dijkhuizen, Federica Del Chierico, Clara Malattia, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 10, 2018
Reversal of Sepsis-Like Features of Neutrophils by Interleukin-1 Blockade in Patients With Systemic-Onset Juvenile Idiopathic ArthritisNienke M Ter Haar, Tamar Tak, Michal Mokry, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Current Opinion in Rheumatology|March 27, 2014
Treatment of hereditary autoinflammatory diseasesNienke M Ter Haar, Joost Frenkel
Academic Medicine : Journal of the Association of American Medical Colleges|April 22, 2021
Developing Entrustable Professional Activities for the Training of Translational Scientists: A Modified Delphi StudyMargot M Weggemans, Nienke M Ter Haar, Berent Prakken, et al.
Clinical Immunology (Orlando, Fla.)|November 1, 2012
Mevalonate kinase deficiency, a metabolic autoinflammatory diseaseRobert van der Burgh, Nienke M Ter Haar, Marianne L Boes, et al.
Nederlands Tijdschrift Voor Geneeskunde|May 21, 2010
[DIRA: life-threatening but treatable inherited inflammatory disease]Nienke M ter Haar, Annet van Royen, Mariëlle E van Gijn, et al.
Pediatric Rheumatology Online Journal|September 22, 2016
The human microbiome and juvenile idiopathic arthritisAnouk Verwoerd, Nienke M Ter Haar, Sytze de Roock, et al.
JIMD Reports|September 28, 2015
Diagnostic Value of Urinary Mevalonic Acid Excretion in Patients with a Clinical Suspicion of Mevalonate Kinase Deficiency (MKD)Jerold Jeyaratnam, Nienke M Ter Haar, Monique G M de Sain-van der Velden, et al.
Pediatric Rheumatology Online Journal|March 23, 2018
The safety of live-attenuated vaccines in patients using IL-1 or IL-6 blockade: an international surveyJerold Jeyaratnam, Nienke M Ter Haar, Helen J Lachmann, et al.
Rheumatology (Oxford, England)|June 23, 2018
Prediction of inactive disease in juvenile idiopathic arthritis: a multicentre observational cohort studyEvert H Pieter van Dijkhuizen, Orfeas Aidonopoulos, Nienke M Ter Haar, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 29, 2018
Microbiome Analytics of the Gut Microbiota in Patients With Juvenile Idiopathic Arthritis: A Longitudinal Observational Cohort StudyE H Pieter van Dijkhuizen, Federica Del Chierico, Clara Malattia, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 10, 2018
Reversal of Sepsis-Like Features of Neutrophils by Interleukin-1 Blockade in Patients With Systemic-Onset Juvenile Idiopathic ArthritisNienke M Ter Haar, Tamar Tak, Michal Mokry, et al.
Pageof 2